Polynucleotide Hair Loss Treatment in Doncaster

Hair thinning is not a single event but a progressive biological process. The hair follicle operates in a cyclical pattern — the anagen (active growth) phase, the catagen (transition) phase and the telogen (resting) phase — and the duration and quality of the anagen phase determines the length, thickness and density of the hair produced. Under the influence of DHT sensitivity, oxidative stress, chronic scalp inflammation and declining cellular vitality with age, the anagen phase progressively shortens and the quality of the follicular environment supporting it declines. The result is the gradual reduction in hair density and shaft thickness that patients experience as hair thinning.

Polynucleotides — chains of nucleotides derived from highly purified salmon DNA — work by binding to adenosine A2A receptors on the surface of fibroblasts and other target cells in the scalp tissue. This receptor activation triggers a well-documented regenerative cascade: increased fibroblast proliferation, enhanced collagen and extracellular matrix synthesis in the follicular dermal papilla zone, new capillary formation improving follicular blood supply, and a reduction in the pro-inflammatory cytokine activity that drives miniaturisation. Each of these responses directly supports the biological conditions in which healthy hair follicle function is maintained.

Consequently, polynucleotide hair loss treatment addresses the root cellular causes of hair thinning rather than simply stimulating the scalp surface — producing improvements in follicular activity, hair shaft quality and scalp health that reflect genuine structural change in the tissue.

Furthermore, polynucleotide hair treatment sits within a comprehensive hair restoration range at Elements Medical that also includes PRF hair treatment and exosomes hair treatment, offering patients a range of evidence-based regenerative approaches to hair thinning.

Our Doncaster clinic is on Thorne Road with on-site parking, and we welcome patients from across South Yorkshire including Rotherham, Wakefield, Sheffield, Leeds and Barnsley.

What Are Polynucleotides and How Do They Work for Hair Loss?

PDRN (polydeoxyribonucleotide) is the active component of polynucleotide injections — a purified extract of short-chain DNA fragments derived from salmon sperm DNA, which shares a high degree of structural compatibility with human DNA. When injected into the scalp, PDRN exerts its biological effect through the following mechanisms:

Adenosine A2A receptor activation: PDRN binds directly to adenosine A2A receptors on fibroblasts and other dermal cells in the scalp. This receptor activation is the primary mechanism through which polynucleotides produce their regenerative effect — it is a direct cellular instruction to increase regenerative activity, not a passive supply of building blocks. Consequently, the cells of the follicular zone are directed to proliferate, produce more structural matrix components and behave in a more youthful, active manner.

Fibroblast proliferation and matrix synthesis: The receptor-activated fibroblasts of the scalp dermis increase their production of collagen and the extracellular matrix components that form the structural support environment around each hair follicle. The dermal papilla — the specialised cluster of cells at the base of each follicle that controls its growth cycle — benefits directly from this improved structural environment.

Angiogenesis — improved scalp blood supply: PDRN stimulates angiogenesis, the formation of new capillaries in the treated tissue. For the scalp, improved vascularisation means better delivery of oxygen, nutrients and growth signals to the follicular zone — one of the most important determinants of sustained follicular function and hair quality.

Anti-inflammatory activity: PDRN has well-documented anti-inflammatory properties, reducing the production of pro-inflammatory cytokines in the treated tissue. Chronic low-level scalp inflammation is a significant and often underappreciated driver of follicular miniaturisation — reducing it directly improves the cellular environment in which follicles operate.

Salvage pathway nucleotide recycling: The DNA fragments in PDRN can be broken down and recycled through the cell’s nucleotide salvage pathway, providing raw material for DNA synthesis and repair in the actively dividing cells of the follicular zone — supporting the cellular energy and division processes underpinning hair growth.

The clinical evidence for PDRN and polynucleotide therapy in follicular regeneration and scalp health is supported by peer-reviewed research. British Journal of Dermatology — polynucleotides and tissue regeneration (

How Is Polynucleotide Hair Loss Treatment Performed? Step by Step

Before treatment:

• Wash your hair before your appointment — arrive with a clean scalp free from styling products
• Avoid blood-thinning supplements, alcohol and non-essential NSAIDs for 24 hours before treatment to minimise bruising and injection site sensitivity
• Topical anaesthetic cream is applied to the scalp approximately 20 to 30 minutes before injections to maximise comfort

During treatment:

• The scalp is thoroughly cleansed
• PDRN is injected in a series of precise, shallow intradermal injections across the treatment area of the scalp — typically the crown, frontal hairline and areas of greatest thinning
• Small papule blebs (raised bumps at injection sites) appear immediately after injection — this is normal and expected, indicating correct superficial placement of the product
• The procedure takes approximately 30 minutes

After treatment:

• Papule blebs typically resolve within 24 to 72 hours as the PDRN disperses through the scalp tissue
• Mild tenderness, redness and sensitivity in the treated scalp area are normal and resolve within 24 to 48 hours
• Avoid washing your hair or applying products to the scalp for 24 hours following treatment
• Avoid saunas, swimming and intense exercise for 24 hours
• Return to normal activities same day or next day
• Visible improvements in hair quality and early signs of improved follicular activity typically become apparent from four to six weeks after the first session
• Maximum results develop across and following a full course of four sessions at four-week intervals

3 Purposes of Polynucleotide Hair Loss Treatment

1. Restoring the Follicular Environment Through Receptor-Level Cellular Regeneration

The primary purpose of polynucleotide hair loss treatment is to restore the cellular conditions in the scalp that support healthy, sustained hair follicle function — by directly activating the regenerative response of the follicular zone cells through adenosine A2A receptor binding. This receptor-level activation produces fibroblast proliferation, improved structural matrix, better scalp vascularity and reduced inflammation simultaneously — addressing the multiple cellular drivers of hair thinning in a single treatment programme.

2. Maintaining Improved Follicular Health Through a Course and Ongoing Maintenance Programme

The regenerative response triggered by each PDRN scalp injection builds progressively across a course of four sessions — each treatment deepening the fibroblast activation, angiogenesis and anti-inflammatory effect established by the previous one. Maintenance sessions at appropriate intervals following the initial course sustain the improved follicular environment against the ongoing effects of ageing, hormonal influence and oxidative stress that progressively challenge hair health over time.

3. Protecting Confidence and Wellbeing by Addressing the Psychological Impact of Hair Thinning

Hair thinning has a consistently documented and significant negative impact on self-esteem and psychological wellbeing — for men and women alike. Providing a non-pharmaceutical, non-surgical injectable treatment that addresses the biological root causes of hair thinning and produces genuine improvements in follicular activity and hair quality offers meaningful relief from one of the most personally significant aesthetic concerns patients present with.

7 Proven Benefits of Polynucleotide Hair Loss Treatment

1. Directly activates follicular regeneration through adenosine A2A receptor binding PDRN binds to receptors on follicular fibroblasts to trigger a directed regenerative response — a more targeted and specific mechanism than passive growth factor delivery or surface stimulation.

2. Stimulates new collagen synthesis in the follicular dermal papilla zone Activated fibroblasts produce new collagen and extracellular matrix components in the structural environment surrounding each follicle, improving the dermal papilla support that determines hair growth cycle quality.

3. Improves scalp vascularity through angiogenesis PDRN-stimulated new capillary formation improves blood supply, oxygen delivery and nutrient availability to the follicular zone — one of the most direct ways of improving the biological conditions for sustained follicular activity.

4. Reduces scalp inflammation — a primary driver of follicular miniaturisation PDRN’s anti-inflammatory activity reduces the chronic pro-inflammatory cytokine activity in the scalp that drives progressive follicular miniaturisation, addressing the cellular environment rather than simply stimulating growth.

5. Works through a well-documented, peer-reviewed biological mechanism The adenosine A2A receptor pathway through which PDRN exerts its effect is one of the most extensively studied mechanisms in regenerative medicine — with a strong evidence base supporting both its safety and its efficacy in tissue regeneration applications.

6. Minimal downtime — return to normal activities same day or next day Mild scalp tenderness and papule blebs resolve within one to three days. Normal activities can be resumed the same day or the following morning.

7. Combines with PRF and exosomes hair treatments for a comprehensive scalp regeneration programme Polynucleotide hair treatment works through receptor-level cellular activation; PRF hair treatment contributes autologous growth factors; exosomes hair treatment adds a high-concentration exosome and growth factor supply via microneedling. Together they address follicular health from three complementary directions.

What Can Polynucleotide Hair Loss Treatment Address?

Diffuse Hair Thinning in Men and Women

Diffuse thinning — gradual reduction in hair density across the scalp without a sharply defined pattern — is one of the most common presentations and responds well to polynucleotide treatment’s improvements in follicular environment and dermal papilla support. Progressive improvement in hair shaft thickness and density develops across a course as the regenerative response matures.

Early to Moderate Androgenetic Hair Loss

Androgenetic hair loss (male and female pattern hair loss) involves progressive DHT-driven follicular miniaturisation. Polynucleotide treatment addresses the cellular environment that determines follicular resilience to this process — improving the structural support, vascularity and anti-inflammatory conditions that sustain follicular function, and potentially reactivating follicles that have become dormant but are not yet permanently lost.

Post-Partum and Stress-Related Hair Thinning

Temporary hair thinning following pregnancy, periods of significant physiological or psychological stress, or illness — where the hair growth cycle has been disrupted but the follicles themselves are structurally intact — responds particularly well to polynucleotide treatment. The improved follicular environment and reduced scalp inflammation support a more rapid return to a healthy, sustained growth cycle.

Hair Thinning Associated with Scalp Inflammation

Where scalp inflammation is a significant contributor to hair thinning — whether associated with seborrhoeic dermatitis, chronic irritation or other inflammatory scalp conditions — the documented anti-inflammatory activity of PDRN directly addresses one of the primary cellular drivers of the problem.

Polynucleotide Hair Treatment vs PRF Hair Treatment — Understanding the Difference

Both polynucleotide hair treatment and PRF hair treatment inject regenerative biological material directly into the scalp to support follicular reactivation — but through different mechanisms and from different sources.

PRF (Platelet-Rich Fibrin) is derived from the patient’s own blood. Centrifuged to concentrate platelets, growth factors and fibrin, it is injected into the scalp where it releases the patient’s own growth factor profile into the follicular zone. Because it comes from the patient’s blood, it is entirely autologous — there is no external biological material involved. Growth factor concentration varies naturally between patients and sessions.

Polynucleotides work through receptor-level cellular activation — PDRN binds to adenosine A2A receptors on fibroblasts to direct them to regenerate more actively, independently of the growth factor supply. The mechanism is more targeted and consistent between patients.

The two approaches are frequently combined: PRF for its autologous growth factor delivery and fibrin scaffold, polynucleotides for their receptor-activated cellular regeneration and anti-inflammatory activity. Your practitioner will advise on the most appropriate approach for your specific presentation at consultation.

Polynucleotide Hair Treatment vs Exosomes Hair Treatment — Complementary Approaches

Exosomes hair treatment delivers 20 billion bovine colostrum-derived exosomes and 20 growth factors to the scalp via microneedling — supplying the growth factor and signalling environment that supports follicular regeneration from the outside in.

Polynucleotide hair treatment injects PDRN directly into the scalp dermis — activating follicular fibroblasts at the receptor level to direct regeneration from within the cell.

The two mechanisms are complementary: exosomes supply the growth factors and biological signals; polynucleotides activate the receptor that tells the cells to use those signals. Patients with moderate to significant hair thinning may benefit from a programme incorporating both treatments. Your practitioner will advise on sequencing and suitability at consultation.

Why Choose Elements Medical for Polynucleotide Hair Loss Treatment in Doncaster?

At Elements Medical, polynucleotide hair loss treatment is performed by experienced practitioners with a thorough understanding of scalp anatomy and injectable PDRN technique. Every treatment begins with a consultation to assess your hair loss pattern, scalp condition, suitability and realistic expectations of the treatment timeline and result.

We offer polynucleotide hair treatment as part of a comprehensive hair restoration range alongside PRF hair treatment and exosomes hair treatment. We will always recommend the treatment or combination most appropriate for your presentation and goals.

For polynucleotide treatment of the face, neck and body, see our main Polynucleotides page. For polynucleotide treatment of the eye area, see our Polynucleotide Eye page.

Read what our patients say on our Google Reviews page.